Bristol-Myers Squibb
BMY
#174
Rank
NZ$225.20 B
Marketcap
NZ$110.25
Share price
0.35%
Change (1 day)
43.42%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.22. In 2025 the company made an earnings per share (EPS) of NZ$6.05 an increase over its 2024 EPS that were of NZ-$7.73.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.100.92%
2025NZ$6.05-178.28%
2024NZ-$7.73-213.92%
2023NZ$6.7830.2%
2022NZ$5.21-6.04%
2021NZ$5.55-179.29%
2020NZ-$6.99-281.37%
2019NZ$3.86-27.21%
2018NZ$5.30
2016NZ$4.67175.26%
2015NZ$1.70-19.83%
2014NZ$2.12-22.44%
2013NZ$2.7334.48%
2012NZ$2.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.27 145.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.27 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.60-42.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$49.35 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.32 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.48-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$16.35 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.25 0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.15 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK